Heparin Dose During Percutaneous Coronary Intervention: How Low Dare We Go?

Heart
doi 10.1136/heart.88.4.331
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Heparin for Coronary Angioplasty: High Dose, Low Dose, or No Dose?

Heart
Cardiovascular MedicineCardiology
1998English

Factors Affecting the Patient's Skin Dose During Percutaneous Coronary Intervention for Chronic Total Occlusion

Circulation Journal
MedicineCardiovascular MedicineCardiology
2007English

Percutaneous Coronary Intervention

2012English

Two Iatrogenic Dissections During Single Percutaneous Coronary Intervention

Cardiologia Croatica
Cardiovascular MedicineCardiology
2013English

Percutaneous Coronary Intervention

2007English

Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin During Percutaneous Coronary Intervention: Systematic Review and Meta-Analysis

BMJ
2012English

Evaluation of a New Heparin Agent in Percutaneous Coronary Intervention: Results of the Phase 2 Evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial

Circulation
Cardiovascular MedicinePhysiologyCardiology
2010English

Bleeding After Percutaneous Coronary Intervention: Can We Still Ignore the Obvious?

Open Heart
Cardiovascular MedicineCardiology
2014English

Percutaneous Coronary Intervention (PCI)

British Journal of Cardiac Nursing
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy